Matteo Frigerio Selected Research

Suspensions

10/2022	Native-tissue prolapse repair: Efficacy and adverse effects of uterosacral ligaments suspension at 10-year follow up.
1/2022	Selective suture removal for the management of buttock pain after uterosacral ligaments suspension.
1/2020	Transvaginal uterosacral ligament hysteropexy versus hysterectomy plus uterosacral ligament suspension: a matched cohort study.
1/2020	Surgical management of dyspareunia after laparoscopic lateral suspension for pelvic organ prolapse.
1/2020	Surgical management of bladder erosion and pelvic pain after laparoscopic lateral suspension for pelvic organ prolapse.
11/2019	Long-term outcomes and five-year recurrence-free survival curves after native-tissue prolapse repair.
11/2018	Transvaginal native-tissue repair of enterocele.
8/2018	Transvaginal native-tissue repair of vaginal vault prolapse.
6/2018	Risk factors for stress urinary incontinence after native-tissue vaginal repair of pelvic organ prolapse.
5/2018	Outcomes of Transvaginal High Uterosacral Ligaments Suspension: Over 500-Patient Single-Center Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Frigerio Research Topics

Disease

14	Prolapse 11/2022 - 07/2016
11	Pelvic Organ Prolapse 01/2020 - 01/2017
5	Stress Urinary Incontinence 06/2022 - 12/2017
3	Pain (Aches) 01/2022 - 01/2021
2	Urinary Incontinence 11/2022 - 01/2019
2	Shoulder Dystocia 07/2022 - 02/2018
2	Dyspareunia 01/2020 - 01/2020
1	Vesicovaginal Fistula 11/2022
1	Pelvic Floor Disorders 06/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Ovarian Neoplasms (Ovarian Cancer) 03/2022
1	Overactive Urinary Bladder (Overactive Bladder) 01/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Uterine Prolapse (Vaginal Prolapse) 02/2021
1	Necrosis 02/2021
1	Ischemia 02/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2020
1	Hemorrhage 01/2020
1	Pelvic Pain 01/2020
1	Lacerations 01/2019
1	Rectocele 01/2019
1	Cystocele 01/2019
1	Hernia (Hernias) 11/2018
1	Morbid Obesity 02/2018
1	Birth Weight (Birth Weights) 02/2018
1	Placenta Accreta 01/2018
1	Fistula 01/2018
1	Underactive Urinary Bladder 01/2018
1	Rectovaginal Fistula 05/2016

Drug/Important Bio-Agent (IBA)

14	SuspensionsIBA 10/2022 - 01/2017
2	Oxytocin (Pitocin)FDA LinkGeneric 07/2022 - 02/2018
1	Nicotine FDA Link 06/2022
1	Estrogens (Estrogen)FDA Link 04/2022
1	Levonorgestrel (Plan B)FDA LinkGeneric 03/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2018
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2018
1	Biological ProductsIBA 06/2017
1	CollagenIBA 06/2017

Therapy/Procedure

6	Hysterectomy 12/2021 - 01/2018
4	Vaginal Hysterectomy 05/2018 - 07/2016
3	Suburethral Slings (Tension-Free Vaginal Tape) 06/2022 - 12/2017
2	Therapeutics 06/2022 - 01/2022
2	Operative Time 12/2021 - 01/2020
2	Pessaries 02/2021 - 01/2018
1	Ambulatory Care (Outpatient Care) 11/2022
1	Radiotherapy 11/2022
1	Laser Therapy (Surgery, Laser) 04/2022
1	Intrauterine Devices (Intrauterine Device) 03/2022
1	Sutures (Suture) 01/2022
1	Injections 01/2022
1	Surgical Amputation (Amputations) 02/2021
1	Surgical Instruments (Clip) 02/2021
1	Anesthesia 02/2021
1	Tourniquets 02/2021
1	Episiotomy 01/2019
1	Operative Surgical Procedures 01/2018
1	Cesarean Section (Caesarean Section) 01/2018
1	Gynecologic Surgical Procedures (Gynecologic Surgery) 05/2016